EMA: Guideline on medicinal products for the treatment of insomnia

This Guideline should be considered as general guidance on the development for medicinal products for acute and long-term treatment of insomnia. Its main focus is on primary insomnia, however, it also covers some issues on secondary or co-morbid insomnia. This document should be read in conjunction with other relevant EMA and ICH guidelines.